Australian and New Zealand three-dimensional conformal radiation therapy consensus guidelines for prostate cancer

Marketa Skala, M. Berry, G. Duchesne, K. Gogna, Keen Hun Tai*, S. Turner, A. Kneebone, A. Rolfo, A. Haworth

*Corresponding author for this work

    Research output: Contribution to journalReview articlepeer-review

    22 Citations (Scopus)


    Three-dimensional conformal radiation therapy (3DCRT) has been shown to reduce normal tissue toxicity and allow dose escalation in the curative treatment of prostate cancer. The Faculty of Radiation Oncology Genito-Urinary Group initiated a consensus process to generate evidence-based guidelines for the safe and effective implementation of 3DCRT. All radiation oncology departments in Australia and New Zealand were invited to complete a survey of their prostate practice and to send representatives to a consensus workshop. After a review of the evidence, key issues were identified and debated. If agreement was not reached, working parties were formed to make recommendations. Draft guidelines were circulated to workshop participants for approval prior to publication. Where possible, evidence-based recommendations have been made with regard to patient selection, risk stratification, simulation, planning, treatment delivery and toxicity reporting. This is the first time a group of radiation therapists, physicists and oncologists representing professional radiotherapy practice across Australia and New Zealand have worked together to develop best-practice guidelines. These guidelines should serve as a baseline for prospective clinical trials, outcome research and quality assurance.

    Original languageEnglish
    Pages (from-to)493-501
    Number of pages9
    JournalAustralasian Radiology
    Issue number4
    Publication statusPublished - Dec 2004


    • 3-D conformal therapy
    • Consensus development conference
    • Dose escalation
    • Practice guidelines
    • Prostatic neoplasms

    Fingerprint Dive into the research topics of 'Australian and New Zealand three-dimensional conformal radiation therapy consensus guidelines for prostate cancer'. Together they form a unique fingerprint.

    Cite this